Inogen, the Goleta-based maker of direct-to-consumer respiratory products, on April 27 reported fourth-quarter profit of $1.5 million. The company said it had net income of 7 cents per share. Earnings, adjusted for pretax gains, were 6 cents per share. Inogen, which produces oxygen concentrators for patients suffering from chronic respiratory conditions, posted revenue of $29.1 Read More →
By Henry Dubroff / Friday, January 16th, 2015 / Columns, Latest news, Opinion / Comments Off on Dubroff: UCSB diabetes researcher refines fine art of forecasting behavior
Advances such as tablet technology and cloud computing mean that a fully commercial product to reliably regulate insulin might be within reach.
By Guest commentary / Friday, November 28th, 2014 / Op/Eds, Opinion / Comments Off on Op/ed: Report on Isla Vista gets an ‘incomplete’
I certainly agree with the independent committee that Isla Vista suffers from “inadequate representation, insufficient public services and a lack of infrastructure . . .” But that’s been the reality for 50 years, and the question remains: “What do we do about it?
By Editorial Board / Friday, November 21st, 2014 / Editorials, Opinion / Comments Off on Editorial: Tuition hike won’t end calls for reform at UC
A not-so-stealthy issue in the debate over the University of California’s proposed tuition hikes is the growing economic gap between the system’s 10 campuses and the communities they serve.
By Henry Dubroff / Friday, November 21st, 2014 / Columns, Opinion / Comments Off on Dubroff: Isla Vista study takes a first crack at changing community culture
Nearly six months after the tragic killings that left seven people dead in Isla Vista, UC Santa Barbara has taken the initial, tentative steps toward re-examining how to better integrate the off-campus community into the rest of the South Coast.
Inogen has benefited from the October release of its Inogen at Home product, which is the lightest continuous-flow oxygen concentrator available to consumers. It successfully floated an additional 2.4 million shares sold by existing stockholders and has announced an expanded credit line with J.P. Morgan Chase.
